Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
135,488,140
-
Total 13F shares
-
15,003,494
-
Share change
-
-303,415
-
Total reported value
-
$64,925,247
-
Put/Call ratio
-
26%
-
Price per share
-
$4.33
-
Number of holders
-
54
-
Value change
-
+$4,077,592
-
Number of buys
-
24
-
Number of sells
-
28
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q3 2017
As of 30 Sep 2017,
ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,003,494 shares.
The largest 10 holders included
OppenheimerFunds, Inc., VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, D. E. Shaw & Co., Inc., ING GROEP NV, GEODE CAPITAL MANAGEMENT, LLC, Allianz Asset Management GmbH, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and A.R.T. Advisors, LLC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.